SOLICITATION NOTICE
99 -- Monoclonal Antibody Generation
- Notice Date
- 11/19/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 427, Room 12, Frederick, MD, 21702, UNITED STATES
- ZIP Code
- 21702
- Solicitation Number
- S08-060
- Response Due
- 12/17/2007
- Point of Contact
- Melissa Borucki, Subcontract Specialist, Phone 301/228-4041, Fax 301/228-4037
- E-Mail Address
-
mborucki@ncifcrf.gov
- Description
- SAIC-Frederick, the Operations and Maintenance Contractor for the NCI Frederick Cancer Research Facility is soliciting for the services described herein on behalf of the NCI. The NCI Clinical Proteomic Technologies for Cancer (CPTC) initiative was established with the goal of creating technologies, data, reagents and reference materials, analysis systems and infrastructure as a basis for advancing discovery research and clinical applications. More information about the initiative can be found at http://proteomics.cancer.gov. As part of the CPTC, a series of renewable and highly characterized affinity binding reagents will be generated and made available to the research community. Detailed standard operating procedures (SOP?s) will be made available along with characterization data through a web portal. This will ensure that experiments can be both repeated and compared among researchers. The specific objective of this scope of work is to generate antibodies from antigens already generated under the CPTC. There are forty-two antigens that will be used in the generation and screening for new monoclonal antibodies. Once a set of antibodies are generated and screened by the contractor for each antigen, the antibodies will be sent to SAIC-F and undergo further screening and characterization including but not limited to Western Blot, enzyme immunoassay (EIA), surface plasmon resonance (SPR), immuno capture and mass spectrometry, and immuno histochemistry (IHC). The data from all phases of the characterization, i.e. from contractor and other entities selected by NCI will be made public through the associated web portal. The final antibodies and associated hybridoma cells will be made available to the scientific community through a distributor or repository selected by the NCI. The RFP is intended to solicit responses from parties interested in providing the antibodies to the NCI CPTC. Multiple contracts may be issued. Full RFP to be posted by end of day 11/19/07. NOTE: THIS NOTICE MAY HAVE POSTED ON FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (19-NOV-2007). IT ACTUALLY APPEARED OR REAPPEARED ON THE FEDBIZOPPS SYSTEM ON 18-DEC-2007, BUT REAPPEARED IN THE FTP FEED FOR THIS POSTING DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.fbo.gov/spg/HHS/NIH/FCRF/S08-060/listing.html)
- Place of Performance
- Address: Contractor Facility
- Zip Code: 00000
- Country: UNITED STATES
- Zip Code: 00000
- Record
- SN01472700-F 20071220/071218230103 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |